Navigation Links
Topical treatment may prevent melanoma
Date:4/26/2011

While incidents of melanoma continue to increase despite the use of sunscreen and skin screenings, a topical compound called ISC-4 may prevent melanoma lesion formation, according to Penn State College of Medicine researchers.

"The steady increase in melanoma incidence suggests that additional preventive approaches are needed to complement these existing strategies," said Gavin Robertson, Ph.D., professor of pharmacology, pathology, dermatology and surgery, and director of Penn State Hershey Melanoma Center.

Researchers targeted the protein Akt3, which plays a central role in 70 percent of melanoma by preventing cell death and has the potential to prevent early stages of melanoma.

"The Akt3 signaling pathway is deregulated in the majority of melanomas, making it a promising target which, if inhibited, could correct the apoptotic -- or cell death -- defect in melanocytic lesions, thereby preventing this disease," Robertson said.

Isothiocyantes were identified as inhibitors of Akt3. These are naturally occurring compounds found in cruciferous vegetables like broccoli and brussels sprouts that have anticancer properties. Unfortunately, previous research showed they have low chemotherapy potency on melanoma cells because high concentrations are needed to be effective. To create a more potent version, Penn State Hershey Melanoma Center researchers previously developed isoselenocyanates (ISC-4), by replacing sulfur with selenium.

Researchers have now found that repeated topical application of ISC-4 can reduce tumor cell expansion in laboratory-generated human skin by 80 to 90 percent and decrease tumor development in mice skin by about 80 percent. The research also showed that the use of the compound is safe. The research was recently reported in Cancer Prevention Research and featured on the journal cover.

To be an effective preventative agent, a substance needs to kill the melanoma cells while having little effect on normal cells. Researchers learned that ISC-4 kills melanoma cells two to five times more effectively than it kills normal cells. In addition, examination of the treated skin showed no obvious damage to skin cells or skin structure, and treated animals did not show signs of major organ-related toxicity. This indicates a potential for use as a topical application.

"ISC-4 prevented melanoma by decreasing Akt3 signaling that led to a three-fold increase in apoptosis rates," Robertson said. "Thus, topical ISC-4 can delay or slow down melanocytic lesion or melanoma development in preclinical models and could impact melanoma incidence rates, if similar results are observed in humans."

Currently, surgical excision is used to remove melanocytic lesions or prevent development into more aggressive cancer. Topical ISC-4 treatment could potentially be an alternative to surgery for some patients.

"Topical or localized treatments, such as those we propose for ISC-4, could permit the use of high local concentrations with minimal toxicity and be useful for treating cutaneous lesions not amenable to surgical removal or other currently available approaches," Robertson said.

"With more than $1 billion spent on sunscreen every year in the United States, the market for skin cancer prevention is enormous and continues to grow," Robertson said. "Addition of agents such as ISC-4 to sunscreens, body lotions or creams could have a profound impact on this market for preventing melanoma."


'/>"/>

Contact: Matt Solovey
msolovey@hmc.psu.edu
717-531-8606
Penn State
Source:Eurekalert

Related medicine news :

1. Ancient Minerals Topical Magnesium Oil Now Available in the UK
2. COPPERTONE(R) Solar Research Center Unveils Studies on Efficacy of Topical Antioxidants in Sunscreens at 2010 Annual Meeting of The American Academy of Dermatology
3. Topical Drugs May Pollute Waterways
4. Hair Loss Doctor Overcomes Odds To Produce First Ever Combination Topical Hair Growth Formula
5. Use of topical corticosteroids in children with eczema does not have negative side effects
6. Despite Treatment, Employees with Depression Generate Higher Absentee Costs, According to Thomson Reuters Study
7. Women More Likely to Fail Treatment for Atrial Fibrillation
8. Social Anxiety and Panic - Alternative Treatment to Drugs and Therapy
9. Neuroimaging study may pave way for effective Alzheimers treatments
10. Nanofilm Introduces Clarity Defog It™ Anti Fog Treatment and EcoClens™ Eco-Friendly Lens Cleaner at Vision Expo East
11. Many veterans not getting enough treatment for PTSD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... ... January 20, 2017 , ... ... to enhance people’s everyday lives, recently attended the January ECRM Trade Show in ... Science is known for its large range of supplements that keep the body ...
(Date:1/20/2017)... ... January 20, 2017 , ... "TransFlare 4K Mystique comes with 44 ... Cut Pro X," said Christina Austin - CEO of Pixel Film Studios. , ... Dragon Sensor,TransFlare 4K Mystique lens flare and light leak transitions have a very high-dynamic ...
(Date:1/20/2017)... ... January 20, 2017 , ... “The Angel”: a heartwarming and ... out for each of his children. “The Angel” is the creation of published author, ... New York City, and impassioned writer. , When asked of her new book, Marjorie ...
(Date:1/20/2017)... ... January 20, 2017 , ... ... Oscillating Positive Expiratory Pressure (OPEP) device, was featured in a study indicating superior ... MEd, RRT-ACCS, FAARC, “Analysis of Three Oscillating Positive Expiratory Pressure Devices During ...
(Date:1/20/2017)... , ... January 20, 2017 , ... “Knowledge is God’s ... guided by faith. “Knowledge is God’s Lighthouse” is the creation of published author, Gene ... novels, and poetry collections. , “I have been writing since high school and ...
Breaking Medicine News(10 mins):
(Date:1/20/2017)... -- Research and Markets has announced the addition ... Future" report to their offering. ... This research service on the global pharmaceutical ... provides a snapshot of the key participants in the market. ... from 2016 to 2020. The market is expected to grow at ...
(Date:1/20/2017)... Jan. 20, 2017 Wells Specialty Pharmacy announces the ... Branch Rd in Winter Park, Florida ... . Operations have been consolidated into the 3796 Howell ... pleased to announce that Chad Tomlinson , former Vice ... Company effective immediately. Mr. Tomlinson is a Graduate of Florida ...
(Date:1/20/2017)... Avillion LLP, a co-developer and financier of late-stage pharmaceutical ... MBA as Chief Medical Officer. Dr Weinberg will be based in ... ... more than 17 years as a pharmaceutical and biotech executive with ... the course of his career, he has interfaced with the US ...
Breaking Medicine Technology: